![](/img/cover-not-exists.png)
PCN36 COST IMPLICATIONS OF RESTRICTING PALONOSETRON UTILIZATION FOR THE TREATMENT OF CINV: RESULTS FROM AN ANALYTIC MODEL FROM A PAYER PERSPECTIVE
A Powers, E Sarnes, RL Knoth, S Balu, D BuchnerVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71932-5
File:
PDF, 70 KB
english, 2010